| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |